Buenos Aires - Delayed Quote ARS

Mirgor Sociedad Anónima, Comercial, Industrial, Financiera, Inmobiliaria y Agropecuaria (MIRG.BA)

23,750.00

+325.00

+(1.39%)

At close: April 25 at 4:59:59 PM GMT-3

Stock market today: S&P 500, Dow, Nasdaq futures slip ahead of huge week of Big Tech earnings, economic data

US futures slip slightly with investors focused on Big Tech earnings for the week ahead.

Yahoo Finance 14 minutes ago

NQ=F

YM=F

ES=F
Deliveroo shares shoot higher after US takeover proposal

On Monday, Deliveroo also suspended its £100 million share buyback programme as a result of the takeover talks.

PA Media: Money 2 minutes ago

DLVEY
Atos announces the appointment of Marie de Scorbiac as Head of Investor Relations and CSR

Press Release Atos announces the appointment of Marie de Scorbiac as Head of Investor Relations and CSR Paris, France – April 28, 2025 – Atos Group today announces the appointment of Marie de Scorbiac as head of investor relations and CSR. Her mission will be to define and implement the Atos Group's financial reporting strategy and develop its relations with shareholders, investors and financial analysts. She will also oversee Atos's CSR strategy in favor of a secure and decarbonized digital wor

GlobeNewswire 5 minutes ago

AEXAD

AEXAY
FTSE 100 LIVE: Markets flash green with key earnings around the corner

Markets were also boosted by the prospect of a quieter geopolitical environment, as the US attempts to smooth the wrinkles in its relationships with other global powers.

Yahoo Finance UK 11 minutes ago

V

HSBC

DX-Y.NYB
Germany’s Merck Set to Buy SpringWorks in $3.9 Billion Deal

The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.

The Wall Street Journal 1 hour ago

SWTX

MKGAF

MKKGY
Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business

– Purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of $3.4 billion (€3.0 billion) – – Planned acquisition will immediately add revenue and accelerate mid- to long-term growth for Merck KGaA, Darmstadt, Germany’s Healthcare business – – SpringWorks Therapeutics is a U.S. biopharmaceutical company with a first-in-class, systemic standard-of-care therapy in adults with desmoid tumors and the first and only approved therapy for

GlobeNewswire 1 hour ago

MKGAF

MKKGY

SWTX
5 vital but difficult questions to ask family members

If we don’t have key conversations with older members of the family, it will make life even more difficult when they pass away.

Yahoo Finance UK 3 hours ago

GBPUSD=X

USD=X

GBP=X
India's Reliance jumps as telecom, retail boost brightens outlook

(Reuters) -Shares of India's Reliance Industries jumped 4% on Monday as investors cheered strength in its telecom and retail businesses after a quarterly profit beat, prompting analysts to upgrade the stock after months of underperformance. Over the last year, the billionaire Mukesh Ambani-led conglomerate has done worse than India's benchmark Nifty 50 index, which Jefferies said was amid concerns of a slowdown in its retail business. Analysts see the trend changing after Reliance beat fourth-quarter profit estimates, largely boosted by its retail and telecom units.

Reuters 4 hours ago

^YH309
Private Equity Firms Target Defense Assets Once Seen as Toxic

(Bloomberg) -- Private equity firms are scouring for investment opportunities in European defense, chasing the once shunned sector in an effort to benefit from a historic switch to military expansion in the region.Most Read from BloombergWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesNewsom Says California Is Now the World’s Fourth-Biggest EconomyAt Bryn Mawr, a Monumental Plaza Traces the Steps of Black HistoryLos Angeles Downgraded to AA- by S&P Due to Budget WoesUS Cricket Deepens

Bloomberg 4 hours ago

IVCGF

KKR

KKR-PD
Gold’s bullish sentiment seen easing as record rally stumbles

(Bloomberg) -- The gold rally has outshone other asset classes this month — even drawing some comparisons to bitcoin — as President Donald Trump’s tariff war reshapes the global economic order, pushing investors to look for safety. Now, shifts in options positioning has some market watchers saying it’s time to get cautious. Most Read from BloombergWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesNewsom Says California Is Now the World’s Fourth-Biggest EconomyAt Bryn Mawr, a Monumental

Bloomberg 4 hours ago

BCS

GC=F

BTC-USD
Indian shares rise as Reliance results, foreign inflows boost sentiment

The Nifty 50 was up 0.9% at 24,255.55 and the BSE Sensex gained 0.98% to 79,989.97 as of 10:33 a.m. IST. Around a third of the Nifty's gains came from oil-to-telecom conglomerate Reliance Industries, which jumped 3% and hit a six-month high after beating analysts' estimates for quarterly earnings. "RIL's analyst meeting had a confident tone on the outlook for consumer retail growth normalisation back to double digits and domestic fuel sales increases, with details on ramp-up of the new energy vertical," Morgan Stanley said in a note.

Reuters 5 hours ago

^YH309
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

STAMFORD, Conn., April 27, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company anticipates the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) will adopt an opinion on the marketing authorization application (MAA) for nirogacestat, an oral gamma secretase inhibitor, for the treatment of adults with desmoid tumor

GlobeNewswire 17 hours ago

SWTX
Toyota considers investing in potential $42 billion buyout of key supplier

TOKYO (Reuters) -Toyota Motor said it is exploring the possibility of investing in a potential buyout of key parts supplier Toyota Industries - a buyout that reportedly could cost $42 billion. "We are currently exploring various possibilities, including partial investment," the automaker said in a filing with the Tokyo stock exchange on Saturday following reports about the possible buyout. Bloomberg News reported on Friday that Toyota Chairman Akio Toyoda and his founder family have proposed acquiring Toyota Industries in a possible 6 trillion yen ($42 billion) deal.

Reuters yesterday

TM

TYIDY
'People hung up on us in our goal to become the Dyson of ice baths'

Brass Monkey was launched in 2021 and is now an ice bath leader in the UK with an anticipated turnover of £7 million.

Yahoo Finance UK yesterday

^FTSE
Succeeding With This Stock May Require Investors to Out-Buffett Warren Buffett. Here's Why.

Warren Buffett's Berkshire Hathaway sold more stock than it bought in 2024, so it likely raised some eyebrows when the company revealed its position in Constellation Brands (NYSE: STZ). This could mean that Berkshire needs to lean more into Buffett's strategy and not less.

Motley Fool yesterday

STZ

^GSPC
Akeso survival data for ivonescimab misses expectations, STAT says

While Akeso (AKESF) and Summit Therapeutics’ (SMMT) ivonescimab, a rival to Merck’s (MRK) Keytruda, won approval in China this week, the data on patient survival did not meet analyst expectations, Jonathan Wosen of STAT reports. In its submission to regulators, Akeso included data on patient survival, disclosing that an interim analysis following 157 patient deaths found that participants on ivonescimab had a roughly 22% reduced risk of death, with a hazard ratio of 0.784, a company spokesperson

TipRanks yesterday

BNTX

SMMT

MRK
China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz

The major averages were mixed near noon following several days of gains as investors process the latest batch of earnings reports, including a notable one from a big tech bellwether. Optimism over easing U.S.-China trade tensions, particularly with China reportedly considering tariff exemptions for certain American products, is also being weighed, though President Trump said he would consider it a “total victory” if the U.S. has high tariffs of 20%-50% on foreign nations a year from now, accordi

TipRanks yesterday

LOW

TMUS

GOOG
Tesla Vs. BYD: EV Giants' Earnings Diverge Wildly, But Both Stocks Soar

BYD's Q1 net income doubled vs. a year earlier, passing Tesla for the first time. Tesla earnings dived, but Elon Musk is still bullish on robotaxis. Both stocks soared.

Investor's Business Daily yesterday

TSLA

BYDDY
The Weekend: When signs of a US-China trade deal brought relief to anxious markets

Key moments from the last seven days, plus a glimpse at the week ahead

Yahoo Finance UK yesterday

AMZN

RYDAF

SHEL
Better AI Stock: BigBear.ai vs. C3.ai

Which of these unloved AI stocks can make a comeback?

Motley Fool yesterday

AI

BBAI-WS

Performance Overview

Return	MIRG.BA	MERVAL (M.BA)
YTD	-8.92%	-36.71%
1-Year	+69.29%	+28.78%
3-Year	+600.75%	+1,659.13%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Mirgor Sociedad Anónima, Comercial, Industrial, Financiera, Inmobiliaria y Agropecuaria (MIRG.BA)

Related News

Stock market today: S&P 500, Dow, Nasdaq futures slip ahead of huge week of Big Tech earnings, economic data

Deliveroo shares shoot higher after US takeover proposal

Atos announces the appointment of Marie de Scorbiac as Head of Investor Relations and CSR

FTSE 100 LIVE: Markets flash green with key earnings around the corner

Germany’s Merck Set to Buy SpringWorks in $3.9 Billion Deal

Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business

5 vital but difficult questions to ask family members

India's Reliance jumps as telecom, retail boost brightens outlook

Private Equity Firms Target Defense Assets Once Seen as Toxic

Gold’s bullish sentiment seen easing as record rally stumbles

Indian shares rise as Reliance results, foreign inflows boost sentiment

SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union

Toyota considers investing in potential $42 billion buyout of key supplier

'People hung up on us in our goal to become the Dyson of ice baths'

Succeeding With This Stock May Require Investors to Out-Buffett Warren Buffett. Here's Why.

Akeso survival data for ivonescimab misses expectations, STAT says

China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz

Tesla Vs. BYD: EV Giants' Earnings Diverge Wildly, But Both Stocks Soar

The Weekend: When signs of a US-China trade deal brought relief to anxious markets

Better AI Stock: BigBear.ai vs. C3.ai

Performance Overview